| abstract |
New lyophilized unit pharmaceutical form of diosmin, containing: - a predetermined quantity of diosmin of between 30 and 80% of the dry mass of the lyophilisate, - a diluent capable of improving the physical properties of the galenic form and which may constitute up to 'to 70% of the lyophilized dry mass, - one or more suspending agents representing in total 0.05 to 10% of the lyophilized dry mass, - one or more binders constituting in total 0.1 to 20% of the dry mass , - one or more additives intended to: improve the taste, modify the color, improve preservation, - optionally a surfactant. |